SAPHELY logo

News

26 Sep 2018

SAPHELY Final Review meeting
The final review of the SAPHELY project has been held in Valencia (Spain) in the facilities of the Valencian Institute of Oncology (IVO). There, the SAPHELY consortium has presented the findings and outputs of the project to representatives of the European Commission.

Among the work presented, the operation of the final SAPHELY platform, placed in the Molecular Biology Laboratory at IVO, has been shown to the EC representatives.


20 Apr 2018

Meeting of Cancer Researchers of the Valencian Community “Ciudad de Alcoi”
The Valencian Biobanking Network Foundation managed by the Promotion of Health and Biomedical Research of Valencia Region (FISABIO), in collaboration with the Ayuntamiento de Alcoi, the Valencian Institute of Oncology (IVO), the Universitat Politècnica de València and the Club d’Esports de Muntanya +QUEUNTRAIL, have organized a meeting where researchers from the Valencian Region discussed about the main research works being carried out in the field of cancer diagnosis and treatment in this region. This meeting has been held at Alcoi (Valencia) on 20th April 2018. Besides this meeting, a solidarity trail race was also organized to support the research in the field of cancer.

The SAPHELY project has been represented in this meeting by the participation of researchers from UPV and IVO, which contributed with different talks and poster presentations


09 Mar 2018

SAPHELY project in the Photonic Public Private Partnership Annual Meeting 2018
Representatives from the SAPHELY project have participated in the thematic workshop “WG3 LIFE SCIENCE AND HEALTH” in the frame of the Photonic Public Private Partnership (PPP) Annual Meeting 2018 held in Brussels, where results from the SAPHELY project were presented. Besides, thay have participated in the discussions related with the analysis of funded Photonics PPP projects and the strategic-planning process for the new photonics multianual roadmap for the next 10 years.


12 Feb 2018

SAPHELY meeting at Enköping
The 8th meeting of the SAPHELY project has been held at APRtech facilities in Enköping (Sweden). Besides revising the work progress, the partners directly involved in the development of the SAPHELY platform (i.e,. the detection cartridges and the readout platform) spent two days working in cross team collaboration for the proper transference of technical details to the final device.


22 Jun 2017

Summer School "Photonics for Health"
The SAPHELY project was presented at the Summer School “Photonics for Health” held at San Martino di Castrozza (Italy), which was organized by the H2020 POSEIDON project. The Summer School, which was mainly aimed at PhD students, was focused on the different applications of photonic devices in the health field and on the dissemination of the results of some European projects working in this field.


10 March 2016

Meeting of researchers working in cancer diagnosis and treatment
The Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO) organizes a meeting where researchers from the Valencia Region will discuss about the main research works being carried out in this region in the field of cancer diagnosis and treatment. This meeting will be held at Alcoi (Valencia) on 15th March 2016. Besides this meeting, a solidarity trail race will also be organized to support the research in the field of cancer.

The SAPHELY project will be represented in this meeting by the participation of researchers from UPV and IVO, which will contribute with different talks and poster presentations.

Photo

Further information (in Spanish) and promotional video:
Encuentro de Investigadores en Cáncer: "Dando la cara por la Sociedad"


14 December 2015

Looking for post-doctoral and doctoral researchers to work on the development of nanophotonic biosensors
The Nanophotonics Technology Center at the Polytechnic University of Valencia (Spain) is looking for candidates for post-doctoral and doctoral positions. The candidates will work in the development of nanophotonic-based biosensors for their application in the field of medical diagnosis. These biosensors will make use of photonic bandgap structures as sensing elements.

Further information about the offers can be found at the Nanophotonics Technology Center webpage


2 December 2015

Novel approaches for cancer diagnosis: the pigeons
A recent study has shown the ability of common pigeons to reliably distinguish between benign versus malignant tumors when an image of a biopsy of a potential breast tumour was displayed. An average diagnostic accuracy of up to 85% was reached by the pigeons, which increased to an impressive 99% when the most common answer of several pigeons was considered.
These results don't mean that pathologist will be replaced by pigeons in the near future, but these finding can be used to help on assessing the quality of new imaging or processing mistakes, or for training purposes.

Photo

Sources and further information:


9 July 2015

CNBP looking for a new Chair of BioPhotonics
The CNBP (Centre for Nanoscale BioPhotonics) is seeking to appoint its new Chair of BioPhotonics, which will lead the BioPhotonics portion of the CNBP activities at its node at the University of Adelaide. In addition the successful candidate will be offered a leadership role in the Biological Sensing and Medical Diagnostics theme of the Institute for Photonics and Advanced Sensing.

Photo

Further information about the position can be found at The University of Adelaide's webpage.


7 July 2015

EVG's HERCULES: an integral solution for high-volume NIL-based nanofabrication
SAPHELY's partner EVG has released his HERCULES NIL platform, a fully integrated track system that combines cleaning, resist coating and baking pre-processing steps with EVG's proprietary SmartNIL large-area nanoimprint lithography (NIL) process in a single platform. The HERCULES NIL provides a complete, dedicated UV-NIL solution that is ideally suited for high-volume manufacturing of emerging photonic devices (up to 40 wafers-per-hour for 200-mm wafers). It does so by imprinting structures in sizes ranging from tens of nanometers up to several micrometers, thus being suitable for the production of the photonic sensing structures to be developed in the SAPHELY project. This fully integrated approach also minimizes the risk of particle contamination.

Photo

Further information about the HERCULES NIL platform can be found at EVG's webpage.


25 June 2015

SAPHELY introduction at the University of South Australia
Jaime García-Rupérez (coordinator of the SAPHELY project) presented at the Mawson Institute of the University of South Australia (Adelaide, Australia) the research carried out by his group at the Nanophotonics Technology Center of the UPV. Within his talk, Jaime introduced the SAPHELY project to the audience, explaining the approach proposed to achieve a final low-cost and easy-to-use analysis device for early medical diagnosis. Jaime García-Rupérez has also established a collaboration with the Mawson Institute of the University of South Australia. This group works in the development of advanced biosensing systems based on different transduction methods, including photonic-based approaches.

Photo


29 May 2015

Biobank of Fundacion Instituto Valenciano de Oncología (IVO) has been certified with the ISO 9001:2008
The ISO 9001:2008 sets out the requirements of a quality management system that in the context of the Biobank means that all processes have control elements that guaranty the quality of all our activities, which are oriented to the satisfaction of both patients and researchers. At the same time, this certification represents an Institutional commitment towards a continuous improvement of our activities. The implementation of a quality management system has allowed us to define indicators and checkpoints in all our processes, to develop periodical maintenance and training plans resulting in greater staff involvement and effective service. Within the context of Saphely project this certification is a guaranty that the management of biological samples for their use in research is being carried out following the highest quality standards.

Photo

Photo


19 May 2015

SAPHELY introduction at the Centre for Nanoscale BioPhotonics, Australia
Within the frame of the research stay of Jaime García-Rupérez (coordinator of the SAPHELY project) at the Centre for Nanoscale Biophotonics (CNBP), he presented the research carried out by his group at the Nanophotonics Technology Center of the UPV. Among other activities, Jaime introduced the SAPHELY project to the audience, explaining the approach proposed to achieve a final low-cost and easy-to-use analysis device for early medical diagnosis.

Photo


19 May 2015

A great complement for SAPHELY technology
What if, besides being able to make a fast analysis of a blood sample for medical diagnosis as targeted by SAPHELY project, we can be able to get this blood sample without making use of needles and avoid painful pricks? This is the target of the US company Tasso Inc., which is working on the development of their HemoLink system. HemoLink is a low-cost, reduced-size microfluidic-based system that allows getting a blood sample simply by vacuum pressure and can be used by the patient itself. HemoLink project has been funded with US$3 million by DARPA (Defense Advanced Research Projects Agency).

Hemolink photo Hemolink photo

Sources and further information:


13 May 2015

Device for Quick and Early Diagnosis of Cancer
Can you imagine a device that allows a quick and early diagnosis of different types of cancer -specifically, breast, prostate, lung and colorectal – just by analyzing two or three drops of blood? This is the aim of SAPHELY, a European project funded by the EU Horizon 2020 program and led by Jaime García Rupérez, researcher at the Campus of Gandia, along with researchers from the Center for Nanophotonics Technology of the UPV. The project also incorporates the SYM group from the Center for Molecular Recognition and Technological Development as a second partner of the UPV.


9 March 2015

SAPHELY Project Aims to Develop Nanophotonic Technology-Based Device for Early Diagnosis of Cancer
To develop a device based on nanophotonic technology that enables a quick and early diagnosis of different types of cancer –specifically breast, prostate, lung and colorectal– analysing only two or three drops of blood. This is the objective of SAPHELY, a European project funded by the EU's Horizon 2020 programme, led by the Valencia Nanophotonics Technology Center of the Universitat Politècnica de València. The SYM group of Centre for Molecular Recognition and Technological Development is also participating in the project as the second partner from the UPV.


10 February 2015

SAPHELY Project on UPV TV